Angioedema Ppts and 400 published articles

Successful Treatment of Acquired Angioedema Using B-lymphocyte Depletion Therapy
Chang Na, MD, David Podell, MD, Christopher Randolph, David Dreyfus, Denise Kearney
http://residency.med.yale.edu

Angioedema in the Antihypertensive and Lipid-Lowering Treatment
Linda Piller, Charles Ford, Barry Davis, Chuke Nwachuku, Henry Black, Suzanne Oparil, Saib Gappy, Tamrat Retta, Jeffrey Probstfield
https://ccct.sph.uth.tmc.edu/allhat/Slides/Angioedema.ppt

Angioedema of the Intestine
J. Ryan Altman, MD, Charles Van Der Horst, MD
https://medicine.med.unc.edu

Allergy/ Immunology Board Review
http://www.medschool.lsuhsc.edu

Leukocyte/ Immune System  Disorders
http://darwin.wcupa.edu

Anaphylaxis &  Acute Allergic Reactions  in the Emergency Department
Theodore J. Gaeta, DO, MPH, Sunday Clark, MPH, Carlos A. Camargo, Jr., MD, DrPH
http://www.pitt.edu/

Antihypertensive Drugs 
Dr. Amani A. Noory, Khartoum, Sudan
http://www.pitt.edu

Anaphylaxis
Nicole Paradise Black, M.D.
http://pediatrics.uchicago.edu
Review of Cardiovascular and Renal Drugs
http://www.d.umn.edu

Effector Mechanisms of Humoral Immunity
http://physio.ucsf.edu

Allergy And Anaphylaxis: Current State Of The Art
Ray Taylor
http://fd.valenciacollege.edu/

Allergic Reactions & Anaphylaxis Incidence
http://facweb.northseattle.edu

Dermatologic Emergencies 
Amy Y-Y Chen, MD, FAAD
http://www.bumc.bu.edu

Allergy In Alabama
http://www.opt.uab.edu 

Latest 400 Published articles of Angioedema
1.    Health-related Quality of Life in Danish Patients with Hereditary Angioedema Aabom, A., et al., Acta Dermato-Venereologica, 2015. 95(2): p. 225-226.
2.    Hereditary Angioedema: Children Should be Considered for Training in Self-Administration Abdel-Karim, O., A. Dizdarevic, and A. Bygum, Pediatric Dermatology, 2014. 31(6): p. E132-E135.
3.    Angioedema is not just 'deep urticaria' but an entity of its own Aberer, W., Allergy, 2014. 69(5): p. 549-552.
4.    Icatibant for laryngeal hereditary angioedema (HAE) attacks: patient/attack characteristics, r.r.a.s.o.a.t.o.-l.e.s.A., W., et al., Allergy, 2014. 69: p. 489-490.
5.    The Icatibant Outcome Survey: Characterizing Breakthrough Hereditary Angioedema Attacks In Patients Receiving Long-Term Prophylaxis Aberer, W., et al., Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB35-AB35.
6.    Open-label, m.s.o.s.-a.i.f.a.o.h.a.A., W., et al., Allergy, 2014. 69(3): p. 305-314.
7.    Hereditary Angioedema in childhood Abraham, S., A. Bauer, and K. Nemat, Journal Der Deutschen Dermatologischen Gesellschaft, 2014. 12: p. 38-38.
8.    RECURRENT ANGIOEDEMA IN A PATIENT WITH NORMAL LEVELS OF C4, C.I.A.L.N.A., Bernice, et al., American Journal of Kidney Diseases, 2014. 63(5): p. A20-A20.
9.    Angioedema: What We Know and What We Need to Know Foreword Alam, R., Immunology and Allergy Clinics of North America, 2013. 33(4): p. IX-X.
10.    When cosmetic fillers disguises facial angioedema Al-Ghanmi, F., Clinical and Experimental Allergy, 2015. 45(2): p. 493-493.
11.    Hereditary angioedema: a brief review of new developments Altman, K.A. and D.R. Naimi, Current Medical Research and Opinion, 2014. 30(5): p. 923-930.
12.    REDUCING SIDE EFFECTS OF SEVERE ASPARAGINASE REACTIONS (ANAPHYLAXIS): A POSSIBLE ROLE FOR USE OF METHYLENE BLUE AFTER GIVING EPINEPHERINE TO QUICKLY REDUCE ANGIOEDEMA AND HYPOTENSION Anderson, P., et al., Pediatric Blood & Cancer, 2014. 61: p. S255-S255.
13.    CASE REPORT: LUDWIG'S ANGINA PRESENTING AS ANGIOEDEMA Anderson, W.C., R.W. Vandivier, and S.C. Dreskin, Annals of Allergy Asthma & Immunology, 2013. 111(5): p. A69-A69.
14.    BRADYKININ B2 RECEPTOR ANTAGONIST OFF LABEL USE IN SHORT-TERM PROPHYLAXIS IN HEREDITARY ANGIOEDEMA Angeletti, C., et al., International Journal of Immunopathology and Pharmacology, 2014. 27(4): p. 653-659.
15.    Ansary, F. F., E.T.U.O.I.I.F.R.W.C.E.I.C.R.A.B.R.D.P.O.A.T.I.H.A.P. and T.J. Craig, Annals of Allergy Asthma & Immunology, 2014. 113(5): p. A70-A71.
16.    Variants of CEP68 Gene Are Associated with Acute Urticaria/Angioedema Induced by Multiple Non-Steroidal Anti-Inflammatory Drugs Antonio Cornejo-Garcia, J., et al., Plos One, 2014. 9(3).
17.    Genome-wide association study in NSAID-induced acute urticaria/angioedema in Spanish and Han Chinese populations Antonio Cornejo-Garcia, J., et al., Pharmacogenomics, 2013. 14(15): p. 1857-1869.
18.    Upregulation of cytokines and IL-17 in patients with hereditary angioedema Arcoleo, F., et al., Clinical Chemistry and Laboratory Medicine, 2014. 52(5): p. E91-E93.
19.    Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe Aygoeren-Puersuen, E., et al., Orphanet Journal of Rare Diseases, 2014. 9.
20.    Successful pregnancy outcome after treatment with C1-inhibitor concentrate in a patient with hereditary angioedema Baccioglu, A. and A.F. Kalpaklioglu, Allergy, 2014. 69: p. 493-494.
21.    Mutational spectrum of the C1 inhibitor gene in a cohort of Italian patients with hereditary angioedema: description of nine novel mutations Bafunno, V., et al., Allergy, 2014. 69: p. 491-492.
22.    MAST CELL INSTABILITY - UNDERSTANDING URTICARIA, A.A.A.B., Andrew and Ascia, Internal Medicine Journal, 2014. 44: p. 8-8.
23.    Evaluation Of Icatibant Reinjection Of Laryngeal Hereditary Angioedema Attacks: A Pooled Analysis Of Three Phase III Open-Label Extension Studies Baptista, J., et al., Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB36-AB36.
24.    Facial angioedema after taking propionics Barasona Villarejo, M.J., et al., Allergy, 2014. 69: p. 130-130.
25.    The role of icatibant-the B2 bradykinin receptor antagonist-in life-threatening laryngeal angioedema in the ED Bartal, C., et al., American Journal of Emergency Medicine, 2015. 33(3).
26.    Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study Bas, M., et al., Allergy, 2013. 68(11): p. 1452-1459.
27.    A Randomized Trial of Icatibant in ACE-Inhibitor-Induced Angioedema Bas, M., et al., New England Journal of Medicine, 2015. 372(5): p. 418-425.
28.    ANGIOTENSIN-CONVERTING ENZYME INHIBITOR (ACEI) INDUCED ANGIOEDEMA IN THE INTENSIVE CARE UNIT (ICU) Baumgartner, L. and S. Chapman, Critical Care Medicine, 2014. 42(12).
29.    NON-COMPLEMENT DEFICIENCY ANGIOEDEMA RESPONSIVE TO C1 ESTERASE INHIBITOR REPLACEMENT Bayer, D.K., M.M. DeGuzman, and I.C. Hanson, Annals of Allergy Asthma & Immunology, 2013. 111(5): p. A71-A71.
30.    Perspectives on chronic urticaria/angioedema and its treatment Bellanti, J.A. and R.A. Settiane, Allergy and Asthma Proceedings, 2014. 35(1): p. 1-3.
31.    From the Common Cough to Hereditary Angioedema Bellanti, J.A. and R.A. Settipane, Allergy and Asthma Proceedings, 2014. 35(2): p. 89-91.
32.    Wheels within wheals: The burden of urticaria and angioedema Bellanti, J.A. and R.A. Settipane, Allergy and Asthma Proceedings, 2015. 36(2): p. 89-91.
33.    Hereditary angioedema with a focus on the child Bennett, G. and T. Craig, Allergy and Asthma Proceedings, 2015. 36(1): p. 70-73.
34.    Hereditary Angioedema In The Pediatric Patient Bennett, G.H. and T.J. Craig, Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB32-AB32.
35.    Angiotensin Converting Enzyme Inhibitor-induced Gastrointestinal Angioedema A Case Series and Literature Review Benson, B.C., C. Smith, and J.T. Laczek, Journal of Clinical Gastroenterology, 2013. 47(10): p. 844-849.
36.    CHARACTERIZING HEREDITARY ANGIOEDEMA ATTACKS REQUIRING RE-INJECTION OF ICATIBANT: A POOLED ANALYSIS OF THREE PHASE III OPEN-LABEL EXTENSION STUDIES Bernstein, J., et al., Annals of Allergy Asthma & Immunology, 2013. 111(5): p. A49-A50.
37.    Managing hereditary angioedema patients undergoing otolaryngeal procedures Bernstein, J.A., American Journal of Rhinology & Allergy, 2013. 27(6): p. 522-527.
38.    On-demand Therapy for Hereditary Angioedema Bernstein, J.A., Immunology and Allergy Clinics of North America, 2013. 33(4): p. 487-+.
39.    The Effect of Weight on the Efficacy and Safety of C1 Esterase Inhibitor Concentrate for the Treatment of Acute Hereditary Angioedema (vol 36, p., 2014) Bernstein, J. A., Clinical Therapeutics, 2014. 36(6): p. 992-992.
40.    Facilitating home-based treatment of hereditary angioedema Bernstein, J.A., et al., Allergy and Asthma Proceedings, 2015. 36(2): p. 92-99.
41.    Treatment with icatibant in the management of drug induced angioedema Bertazzoni, G., et al., European Review for Medical and Pharmacological Sciences, 2015. 19(1): p. 149-153.
42.    Drug-induced angioedema: experience of Italian emergency departments Bertazzoni, G., et al., Internal and Emergency Medicine, 2014. 9(4): p. 455-462.
43.    Canadian hereditary angioedema guideline Betschel, S., et al., Allergy Asthma and Clinical Immunology, 2014. 10.
44.    Hereditary Angioedema: Moving Therapy into the Home and to Self-Care Betschel, S. and A. Jagdis, Pediatric Allergy Immunology and Pulmonology, 2014. 27(4): p. 181-183.
45.    Angiotensin-converting Enzyme Inhibitor-induced Angioedema Bezalel, S., et al., American Journal of Medicine, 2015. 128(2): p. 120-125.
46.    CME Treatment of hereditary angioedema: a review Bhardwaj, N. and T.J. Craig, Transfusion, 2014. 54(11): p. 2989-2996.
47.    Hereditary angioedema: Treatment and educational therapeutic program Boccon-Gibod, I., Presse Medicale, 2015. 44(1): p. 78-88.
48.    Angioedema and urticaria Boccon-Gibod, I. and L. Bouillet, Annales De Dermatologie Et De Venereologie, 2014. 141: p. S586-S595.
49.    'Angioedema Emergency': a 24/7 phone call service in France Boccon-Gibod, I., L. Bouillet, and A. Pagnier, Allergy, 2014. 69: p. 486-486.
50.    Avoidance of nonsteroidal anti-inflammatory drugs after negative provocation tests in urticaria/angioedema reactions: Real-world experience Bommarito, L., et al., Allergy and Asthma Proceedings, 2014. 35(4): p. 303-306.
51.    DEVELOPMENT AND VALIDATION OF A PATIENT-REPORTED OUTCOME QUESTIONNAIRE FOR THE ASSESSMENT OF HEREDITARY ANGIOEDEMA IN OBSERVATIONAL STUDIES Bonner, N., et al., Annals of Allergy Asthma & Immunology, 2013. 111(5): p. A49-A49.
52.    Hereditary Angioedema with Normal C1 Inhibitor Bork, K., Immunology and Allergy Clinics of North America, 2013. 33(4): p. 457-+.
53.    Icatibant treatment for acute attacks of acquired angioedema due to C1 inhibitor deficiency Bork, K., Allergy, 2014. 69: p. 492-492.
54.    An evidence based therapeutic approach to hereditary and acquired angioedema Bork, K., Current Opinion in Allergy and Clinical Immunology, 2014. 14(4): p. 354-362.
55.    Current drugs in early development for hereditary angioedema: potential for effective treatment Bork, K., Expert Opinion on Investigational Drugs, 2014. 23(7): p. 887-891.
56.    Pasteurized and nanofiltered, p.-d.C.e.i.c.f.t.t.o.h.a.B., Konrad, Immunotherapy, 2014. 6(5): p. 533-551.
57.    Angioedema Bork, K., Immunology and Allergy Clinics of North America, 2014. 34(1): p. 23-+.
58.    Body-weight adjusted dosing of C1-esterase inhibitor for optimal treatment response in acute attacks of laryngeal edema in hereditary angioedema Bork, K., et al., Allergy, 2014. 69: p. 490-490.
59.    C1-Esterase Inhibitor Concentrate For Acute Attacks Of Laryngeal Edema In Hereditary Angioedema (HAE): Fixed Dosing Vs Body Weight-Adjusted Dosing Bork, K., et al., Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB37-AB37.
60.    Progestins are Efficient Agents in Estrogen-sensitive Nonhistaminic Angioedema Reply Bork, K. and J. Hardt, American Journal of Medicine, 2014. 127(10): p. E9-E9.
61.    Characterization of a partial exon 9/intron 9 deletion in the coagulation factor XII gene (F12) detected in two Turkish families with hereditary angioedema and normal C1 inhibitor Bork, K., et al., Haemophilia, 2014. 20(5): p. e372-e375.
62.    Antihistamine-resistant Angioedema in Women with Negative Family History: Estrogens and F12 Gene Mutations Bork, K., et al., American Journal of Medicine, 2013. 126(12).
63.    Estrogens and F12 gene mutations in women with antihistamine-resistant angioedema with normal C1-INH and negative family history Bork, K., et al., Allergy, 2014. 69: p. 87-87.
64.    A CASE OF MULTIPLE MYELOMA MANIFESTING AS LIFE-THREATENING ANGIOEDEMA Bose, S., D. Nayak, and C. Saltoun, Annals of Allergy Asthma & Immunology, 2014. 113(5): p. A76-A76.
65.    Role of the B1 Bradykinin Receptor and gC1qR/p33 in Angioedema Bossi, F. and F. Tedesco, Immunology and Allergy Clinics of North America, 2013. 33(4): p. 535-+.
66.    Oral medicine case book 64: some aspects of the pathophysiology of angioedema with special reference to the upper aerodigestive tract Bouckaert, M., et al., South African Dental Journal, 2014. 69(9): p. 420-423.
67.    Successful and Safe Use Of Icatibant For Life-Threatening Angioedema Attack During Pregnancy In a Patient With Hereditary Angioedema Type I Boufleur, K., et al., Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB36-AB36.
68.    Diagnosis of hereditary angioedema Bouillet, L., Presse Medicale, 2015. 44(1): p. 52-56.
69.    Recurrent angioedema: diagnosis strategy and biological aspects Bouillet, L., et al., European Journal of Dermatology, 2014. 24(3): p. 293-296.
70.    Hereditary angioedema with normal C1 inhibitor in a French cohort: clinical characteristics and response to treatment with icatibant Bouillet, L., et al., Allergy, 2014. 69: p. 52-53.
71.    Efficacy Of C1Inhibitor Concentrate (Berinert) For Severe Angioedema Attacks Induced By Drugs Targeting The Renin-Angiotensin Aldosterone System Bouillet, L., et al., Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB37-AB37.
72.    Hereditary Angioedema in Women Specific Challenges Bouillet, L. and A. Gompel, Immunology and Allergy Clinics of North America, 2013. 33(4): p. 505-+.
73.    VE-cadherin, a.p.m.f.e.c.a.d.h.a.a.B., Laurence and I. Vilgrain, Journal of Allergy and Clinical Immunology, 2014. 134(1): p. 241-241.
74.    Treatment of ACE-inhibitor-related angioedema with icatibant: a case series Bova, M., et al., Allergy, 2014. 69: p. 492-492.
75.    Treatment of ACEI-related angioedema with icatibant: a case series Bova, M., et al., Internal and Emergency Medicine, 2015. 10(3): p. 345-350.
76.    OROFACIAL GRANULOMATOSIS IN A PATIENT WITH HEREDITARY ANGIOEDEMA Brady, S.P. and H.J. Wedner, Annals of Allergy Asthma & Immunology, 2014. 113(5): p. A66-A66.
77.    Angioedema induced by ACE-inhibitors Bregu, B., et al., Allergy, 2014. 69: p. 360-360.
78.    Icatibant as treatment of severe angiotensin receptor blockers induced angioedema. A promising therapeutic solution Brinia, A., et al., Allergy, 2014. 69: p. 581-582.
79.    Angioedema of the upper aerodigestive tract: risk factors associated with airway intervention and management algorithm Brook, C.D., A.K. Devaiah, and E.M. Davis, International Forum of Allergy & Rhinology, 2014. 4(3): p. 239-245.
80.    Is omalizumab effective in cases of angioedema and urticaria unresponsive to treatment? Bulut, I. and Z.F. Ozseker, Allergy, 2014. 69: p. 319-319.
81.    Hereditary Angioedema - Consequences of a New Treatment Paradigm in Denmark Bygum, A., Acta Dermato-Venereologica, 2014. 94(4): p. 436-441.
82.    Angioedema in pediatric heart transplant recipients-reporting C1-esterase inhibitor deficiency without analysing protein Bygum, A. and E.R. Rasmussen, Pediatric Radiology, 2014. 44(7): p. 899-899.
83.    The Icatibant Outcome Survey: experience of hereditary angioedema management from four European countries Caballero, T., et al., Allergy, 2014. 69: p. 54-54.
84.    The humanistic burden of hereditary angioedema: Results from the Burden of Illness Study in Europe Caballero, T., et al., Allergy and Asthma Proceedings, 2014. 35(1): p. 47-53.
85.    Health-Related Quality Of Life (HRQoL) In Adult Patients With Hereditary Angioedema Due To C1 Inhibitor Deficiency (HAE-C1-INH) Assessed By SF-36v2 Caballero, T., et al., Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB34-AB34.
86.    Pathophysiology of Hereditary Angioedema Caccia, S., C. Suffritti, and M. Cicardi, Pediatric Allergy Immunology and Pulmonology, 2014. 27(4): p. 159-163.
87.    Icatibant, a.i.o.b.r., for hereditary angioedema attacks: prospective experimental single-cohort study Campos, Regis Albuquerque, et al., Sao Paulo Medical Journal, 2014. 132(5): p. 261-265.
88.    Icatibant, a.i.o.b.r., for hereditary angioedema attacks: prospective experimental single-cohort study Campos, Regis Albuquerque, et al., Sao Paulo Medical Journal, 2014. 00(ahead): p. 00-00.
89.    DESCRIPTIVE STUDY OF URTICARIA AND ANGIOEDEMA IN ALLERGY AND IMMUNOLOGY DEPARTMENT OF HOSPITAL GENERAL DE MeXICO "DR. EDUARDO LICEAGA" Carino Cartagena, D.A., et al., Annals of Allergy Asthma & Immunology, 2013. 111(5): p. A122-A123.
90.    VE-cadherin, a.p.m.f.e.c.a.d.h.a.a.R.C., Laszlo, E. Kajdacsi, and H. Farkas, Journal of Allergy and Clinical Immunology, 2014. 134(1): p. 241-242.
91.    Angiotensin Converting Enzyme Inhibitor-Related Angioedema: Onset, P., and Management Chan, Norman J. and A.M.S. Soliman, Annals of Otology Rhinology and Laryngology, 2015. 124(2): p. 89-96.
92.    Hereditary angioedema with F12 mutation: factors modifying the clinical phenotype Charignon, D., et al., Allergy, 2014. 69(12): p. 1659-1665.
93.    Angioedema induced by angiotensin converting enzyme inhibitors, p.b.m.-T.i.s.t.w.i.C., Alexandre, et al., Intensive Care Medicine, 2014. 40(6): p. 893-894.
94.    Hereditary angioedema a rare cause of recurrent abdominal pain Chen, X., et al., Pakistan Journal of Medical Sciences, 2014. 30(5): p. 1147-1149.
95.    CLINICAL DECISION-MAKING AND TREATMENT APPROACHES FOR HEREDITARY ANGIOEDEMA: RESULTS OF A NATIONAL SURVEY Chiao, J., et al., Annals of Allergy Asthma & Immunology, 2013. 111(5): p. A105-A105.
96.    Clinical Characteristics of Angioedema With Eosinophilia Cho, H.-J., et al., Allergy Asthma & Immunology Research, 2014. 6(4): p. 362-365.
97.    Idiopathic Angioedema and Urticarial Vasculitis in a Patient with a History of Acquired Haemophilia Christiansen, J., et al., Acta Dermato-Venereologica, 2015. 95(2): p. 227-228.
98.    PHARMACOLOGIC MODELING TO GUIDE THE DX-2930 DOSING REGIMEN IN INVESTIGATING LONG-TERM PROPHYLAXIS OF HEREDITARY ANGIOEDEMA Chyung, Y., et al., Annals of Allergy Asthma & Immunology, 2014. 113(5): p. A106-A106.
99.    Results of a phase 1a, s.a.d.s.o.D.-., a human monoclonal antibody inhibitor of plasma kallikrein under investigation for long-term prophylaxis of hereditary angioedema Chyung, Y., et al., Allergy, 2014. 69: p. 581-581.
100.    Classification, d., and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group Cicardi, M., et al., Allergy, 2014. 69(5): p. 602-616.
101.    Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian experts Cicardi, M., et al., Internal and Emergency Medicine, 2014. 9(1): p. 85-92.
102.    Diagnosing Angioedema Cicardi, M. and A. Zanichelli, Immunology and Allergy Clinics of North America, 2013. 33(4): p. 449-+.
103.    (C1-INH-HAE) Cicardi, M., H.d.o.p.d.C.i.p.I.t.c.d.a.a.p.h.i.a.s.p.w.h.a.d.t.C.i.d., et al., Allergy, 2014. 69: p. 492-493.
104.    From unemployment to empowerment: a patient's journey to home self-treatment for hereditary angioedema Clifford, H., J. Jones, and A. Huissoon, Clinical and Experimental Immunology, 2013. 174: p. 5-5.
105.    SMALL BOWEL ANGIOEDEMA INDUCED BY ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR: US AND CT FINDINGS Coelho, M.L., et al., Jbr-Btr, 2014. 97(4): p. 239-241.
106.    Identification and characterization of a novel splice site mutation in the SERPING1 gene in a family with hereditary angioedema Colobran, R., et al., Clinical Immunology, 2014. 150(2): p. 143-148.
107.    A Novel Splice Site Mutation in the SERPING1 Gene Leads to Haploinsufficiency by Complete Degradation of the Mutant Allele mRNA in a Case of Familial Hereditary Angioedema Colobran, R., et al., Journal of Clinical Immunology, 2014. 34(5): p. 521-523.
108.    Chronic Urticaria/Angioedema and Auto-Immunity: Diagnostic Profile Among Patients Attending a Reference Clinic In Brazil Cordeiro, D.L., et al., Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB122-AB122.
109.    Hereditary Angioedema Without C1 Inhibitor Deficiency: Clinical Evaluation Of 67 Brazilian Patients Cordeiro, E., et al., Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB32-AB32.
110.    A genome-wide association study (GWAS) in patients with urticaria/angioedema induced by hypersensitivity to multiple non-steroidal anti-inflammatory drugs (NIUA) Cornejo-Garcia, J.A., et al., Allergy, 2014. 69: p. 28-28.
111.    Hereditary Angioedema Craig, T., Pediatric Allergy Immunology and Pulmonology, 2014. 27(4): p. 157-158.
112.    INTERNATIONAL PRACTICE OF SELF-ADMINISTRATION IN THE MANAGEMENT OF HEREDITARY ANGIOEDEMA: SURVEY RESULTS AND DISCUSSION FROM AN INTERNATIONAL EXPERT PANEL Craig, T., et al., Annals of Allergy Asthma & Immunology, 2013. 111(5): p. A49-A49.
113.    Diagnosis and Treatment of Bradykinin-Mediated Angioedema: Outcomes from an Angioedema Expert Consensus Meeting Craig, T.J., et al., International Archives of Allergy and Immunology, 2014. 165(2): p. 119-127.
114.    Activation of the ficolin-lectin pathway during attacks of hereditary angioedema Csuka, D., et al., Journal of Allergy and Clinical Immunology, 2014. 134(6): p. 1388-+.
115.    Activation of the ficolin-lectin pathway during attacks of hereditary angioedema Csuka, D., et al., Molecular Immunology, 2013. 56(3): p. 276-276.
116.    INFECTION AS THE CULPRIT IN ANGIOEDEMA Curtiss, M.L., J.T. Anderson, and T. Hwangpo, Annals of Allergy Asthma & Immunology, 2014. 113(5): p. A83-A84.
117.    STEROID REFRACTIVE ANGIOEDEMA ASSOCIATED WITH MILD MAST CELL ACTIVATION AND HISTAMINEMIA Dara, J. and A. Rubinstein, Annals of Allergy Asthma & Immunology, 2014. 113(5): p. A70-A70.
118.    TONGUE OUT OF CHEEK: A UNIQUE CASE OF ACE-INHIBITOR ANGIOEDEMA Dass, K., Annals of Allergy Asthma & Immunology, 2013. 111(5): p. A27-A27.
119.    An Update on the Diagnosis and Management of Hereditary Angioedema With Abnormal C1 Inhibitor Davis-Lorton, M., Journal of Drugs in Dermatology, 2015. 14(2): p. 151-157.
120.    Relationship Between Angioedema Attacks and Health-Related Quality Of Life Outcomes In Patients With Hereditary Angioedema (HAE) Dayno, J., et al., Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB33-AB33.
121.    Enzymatic Assays for the Diagnosis of Bradykinin-Dependent Angioedema (vol 8, e., 2013) Defendi, F., et al., Plos One, 2014. 9(6).
122.    Biological investigation of kinin-mediated angioedema Defendi, F., et al., Annales De Dermatologie Et De Venereologie, 2015. 142(3): p. 163-169.
123.    Increased eNOS levels in hereditary angioedema Demirturk, M., et al., International Immunopharmacology, 2014. 20(1): p. 264-268.
124.    The traumatic effect of angioedema attacks in patients with hereditary angioedema Demirturk, M., et al., Allergy, 2014. 69: p. 494-494.
125.    NSAID-induced urticaria/angioedema does not evolve into chronic urticaria: a 12-year follow-up study Dona, I., et al., Allergy, 2014. 69(4): p. 438-444.
126.    Recurrent angioedema induced by a pacemaker Dordal Culla, M.T., et al., Allergy, 2014. 69: p. 557-557.
127.    Successful Rituximab B Lymphocyte Depletion Therapy for Angioedema due to Acquired C1 inhibitor Protein Deficiency: Association with Reduced C1 inhibitor Protein Autoantibody Titers Dreyfus, D.H., et al., Israel Medical Association Journal, 2014. 16(5): p. 315-316.
128.    PREHOSPITAL MANAGEMENT OF ACUTE ANGIOTENSIN CONVERTING ENZYME INHIBITOR-INDUCED ANGIOEDEMA: A CASE REPORT El Sanadi, N., et al., Annals of Allergy Asthma & Immunology, 2013. 111(5): p. A30-A31.
129.    Hereditary Angioedema in Pregnancy: A Case Report Eleftheriou, G., R. Butera, and M.L. Farina, Birth Defects Research Part a-Clinical and Molecular Teratology, 2014. 100(7): p. 544-544.
130.    Clinical Features Of Pediatric Hereditary Angioedema Elenburg, S.N., et al., Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB32-AB32.
131.    Chronic idiopathic angioedema: a single center experience Eli, M., et al., International Journal of Dermatology, 2014. 53(10): p. E421-E427.
132.    Reply to "A Case of Persistent Angioedema" Escudero Pastor, A.I., Journal of Investigational Allergology and Clinical Immunology, 2014. 24(2): p. 142-142.
133.    Improving Care of Hereditary Angioedema With C1 Inhibitor Deficiency (Type 1 and Type 2 Hereditary Angioedema) in Latin America Fabiani, J., et al., Journal of Investigational Allergology and Clinical Immunology, 2014. 24(6): p. 445-447.
134.    Acquired angioedema Fain, O., et al., Presse Medicale, 2015. 44(1): p. 48-51.
135.    Drug induced angioedema (ACE-inhibitors and other) Fain, O., et al., Presse Medicale, 2015. 44(1): p. 43-47.
136.    Analysis of icatibant reinjection rates for the treatment of laryngeal hereditary angioedema attacks in the FAST-3 open-label extension study Farkas, H., et al., Allergy, 2014. 69: p. 53-53.
137.    Home treatment of attacks with conestat alfa in hereditary angioedema due to C1-inhibitor deficiency Farkas, H., et al., Allergy and Asthma Proceedings, 2014. 35(3): p. 255-259.
138.    Successful prophylaxis with recombinant human C1 inhibitor in a patient with hereditary angioedema Farkas, H., et al., Annals of Allergy Asthma & Immunology, 2015. 114(1): p. 64-65.
139.    Home Treatment With Conestat Alfa In Attacks Of Hereditary Angioedema Due To C1-Inhibitor Deficiency Farkas, H., et al., Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB30-AB30.
140.    Management of pregnancies in a hereditary angioedema patient after treatment with attenuated androgens since childhood Farkas, H., et al., Journal of Obstetrics and Gynaecology, 2015. 35(1): p. 89-90.
141.    Population pharmacokinetics of recombinant human C1 inhibitor in patients with hereditary angioedema Farrell, C., et al., British Journal of Clinical Pharmacology, 2013. 76(6): p. 897-907.
142.    Prognostic factors in outcome of angioedema in the emergency department Felder, S., et al., Allergy and Asthma Proceedings, 2014. 35(5): p. 362-370.
143.    FACTITIOUS ANGIOEDEMA: A CASE SERIES Feldman, M., et al., Annals of Allergy Asthma & Immunology, 2013. 111(5): p. A106-A106.
144.    A case of multicentric Castleman's disease in HIV infection with the rare complication of acquired angioedema Fernando, I. and G. Scott, International Journal of Std & Aids, 2014. 25(7): p. 523-525.
145.    Biochemical comparison of four commercially available C1 esterase inhibitor concentrates for treatment of hereditary angioedema Feussner, A., et al., Transfusion, 2014. 54(10): p. 2566-2573.
146.    Angioedema induced by naproxen without cross-reactivity with other nonsteroidal anti-inflammatory drugs (NSAIDs) Figueroa, J., et al., Allergy, 2014. 69: p. 348-348.
147.    A Novel Mutation in the SERPING1 Gene in Patients with Hereditary Angioedema and a Coexistent Complement Deficiency Firinu, D., et al., Journal of Clinical Immunology, 2014. 34: p. S338-S339.
148.    Emergency management of bradykinin-mediated angioedema Floccard, B., et al., Presse Medicale, 2015. 44(1): p. 70-77.
149.    Angioedema From Recombinant TPA Administration: Case Report and Pathophysiology Review Foster-Goldman, A. and D. McCarthy, American Journal of Therapeutics, 2013. 20(6): p. 691-693.
150.    Depression and anxiety in patients with hereditary angioedema Fouche, A.S., E.F.H. Saunders, and T. Craig, Annals of Allergy Asthma & Immunology, 2014. 112(4): p. 371-375.
151.    Update on Preventive Therapy (Prophylaxis) for Hereditary Angioedema Frank, M.M., Immunology and Allergy Clinics of North America, 2013. 33(4): p. 495-+.
152.    Circulating Extracellular Micrornas In Hereditary Angioedema Gao, P., et al., Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB32-AB32.
153.    Type I hereditary angioedema clinical debut in a 72-years-old female patient Garcia-Menaya, J.M., et al., Allergy, 2014. 69: p. 494-494.
154.    Novel Protocol For Successful Aspirin Desensitization In a Patient With Laryngeal Angioedema To Aspirin Garg, N., P. Patel, and S. Bandi, Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB266-AB266.
155.    The prophylactic use of C1 inhibitor in hereditary angioedema patients undergoing invasive surgical procedures: a retrospective study Gavigan, G., et al., Allergy Asthma and Clinical Immunology, 2014. 10.
156.    Idiopathic angioedema with F12 mutation: is it a new entity? Gelincik, A., et al., Annals of Allergy Asthma & Immunology, 2015. 114(2): p. 154-156.
157.    Clinical features and genetic analyses of type III hereditary angioedema patients Gelincik, A., et al., Allergy, 2014. 69: p. 483-484.
158.    Differential diagnose of angioedema. Acute edematous scleromyxedema Gerstner, S., et al., Hautarzt, 2014. 65(5): p. 454-457.
159.    Tick bite-related meat allergy as a cause of chronic urticaria, a., and anaphylaxis in endemic areas Ghahramani, Grant K. and J. Temprano, International Journal of Dermatology, 2015. 54(2): p. E64-E65.
160.    Angioedema Due to C1 Inhibitor Deficiency: An Argentine Experience Ginaca, A., et al., Journal of Clinical Immunology, 2014. 34: p. S243-S243.
161.    Angioedema Gompel, A., Presse Medicale, 2015. 44(1): p. 28-29.
162.    Hereditary angioedema and hormones Gompel, A., Presse Medicale, 2015. 44(1): p. 65-69.
163.    Progestins are Efficient Agents in Estrogen-sensitive Nonhistaminic Angioedema Gompel, A., O. Fain, and L. Bouillet, American Journal of Medicine, 2014. 127(10): p. E7-E7.
164.    Association of angiotensin-converting enzyme inhibitor-associated angioedema with racecadotril use Gouraud, A., et al., Fundamental & Clinical Pharmacology, 2015. 29: p. 25-25.
165.    Alimentary, M.D.W.A.I.-I.B.A.G., Jatinder and F. Weber, American Journal of Gastroenterology, 2014. 109: p. S318-S318.
166.    RESULTS FROM A MULTICENTER RANDOMIZED CONTROLLED TRIAL OF ECALLANTIDE FOR THE ACUTE TREATMENT OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR INDUCED ANGIOEDEMA Graffeo, C., et al., Annals of Allergy Asthma & Immunology, 2013. 111(5): p. A106-A107.
167.    Bradykinin Mediated Angioedema with ACE Inhibitor in Combination with Immunosupressive Agents Grandeau, E., et al., Therapie, 2014. 69(2): p. 189-192.
168.    Hereditary Angioedema: Report of 68 Cases Grumach, A.S., et al., Journal of Clinical Immunology, 2014. 34: p. S258-S258.
169.    Different clinical profiles in 17 Brazilian families with Hereditary Angioedema without Cl inhibitor deficiency Grumach, A.S., et al., Molecular Immunology, 2014. 61(2): p. 220-221.
170.    Hereditary Angioedema Without C1 Inhibitor Deficiency: Evaluation of 11 Brazilian Families Grumach, A.S., et al., Journal of Clinical Immunology, 2014. 34(3): p. 353-353.
171.    Amitriptyline and bromazepam in the treatment of vibratory angioedema: which role for neuroinflammation? Guarneri, F., C. Guarneri, and H.R. Marini, Dermatologic Therapy, 2014. 27(6): p. 361-364.
172.    Hereditary angioedema: strange cause of abdominal pain Guillermo Salas-Lozano, N., et al., Cirugia Y Cirujanos, 2014. 82(5): p. 563-566.
173.    Adalimumab Desensitization Protocol in a Patient With a Generalized Urticarial Reaction and Angioedema Following Adalimumab Administration Gutierrez Fernandez, D., et al., Journal of Investigational Allergology and Clinical Immunology, 2014. 24(4): p. 273-275.
174.    Histaminergic angioedema and chronic urticaria Hacard, F., et al., Presse Medicale, 2015. 44(1): p. 37-42.
175.    Ace Inhibitor-Induced Visceral Angioedema Haider, A. and H. Kavin, American Journal of Gastroenterology, 2014. 109: p. S420-S420.
176.    Periorbital Subcutaneous Emphysema Mistaken for Unilateral Angioedema During Dental Crown Preparation Haitz, K.A., A.J. Patel, and R.D. Baughman, Jama Dermatology, 2014. 150(8): p. 907-909.
177.    Treatment of acute hereditary angioedema attacks with recombinant C1 inhibitor during pregnancy - a single case experience Hakl, R., P. Kuklinek, and J. Litzman, Allergy, 2014. 69: p. 497-497.
178.    Complexes between the lectin pathway serine protease MASP-1 and C1 inhibitor are associated with severity of Hereditary Angioedema Hansen, C.B., et al., Molecular Immunology, 2014. 61(2): p. 239-239.
179.    Treatment of non-episodic angioedema associated with eosinophilia with suplatast tosilate, a.a.-a.s.T.c.i.H., Hideo and T. Umayahara, European Journal of Dermatology, 2014. 24(2): p. 250-252.
180.    Exploring the cost and burden of illness of hereditary angioedema in England Helbert, M., et al., Allergy, 2014. 69: p. 493-493.
181.    Exploring the burden of illness of hereditary angioedema in the UK Helbert, M., et al., Clinical and Experimental Immunology, 2013. 174: p. 10-10.
182.    RECURRENT FLUSHING AND ANGIOEDEMA WITH INHALED ALBUTEROL Helfner, L., D. Hirsch, and B. Kaplan, Annals of Allergy Asthma & Immunology, 2013. 111(5): p. A33-A33.
183.    Successful use of daily intravenous infusion of C1 esterase inhibitor concentrate in the treatment of a hereditary angioedema patient with ascites, h.s., sepsis, renal and respiratory failure Hoang, Pham, S. Santucci, and W.H. Yang, Allergy Asthma and Clinical Immunology, 2014. 10.
184.    C-reactive protein levels in hereditary angioedema Hofman, Z.L.M., A. Relan, and C.E. Hack, Clinical and Experimental Immunology, 2014. 177(1): p. 280-286.
185.    ACE inhibitor angioedema: a very late presentation Howarth, D., Australian Family Physician, 2013. 42(12): p. 860-862.
186.    SJOGREN'S SYNDROME MASKING AS RECURRENT ANGIOEDEMA Hwangpo, T., P. DeVilliers, and J. Bonner, Annals of Allergy Asthma & Immunology, 2013. 111(5): p. A62-A62.
187.    Urticaria and angioedema with psychogenic triggers Iamandescu, I.B., Journal of Psychosomatic Research, 2014. 76(6): p. 506-506.
188.    TREATMENT OF BETA BLOCKER-INDUCED CUTANEOUS REACTION AND ANGIOEDEMA WITH SYSTEMIC CYCLOSPORINE Imran, M., et al., Annals of Allergy Asthma & Immunology, 2014. 113(5): p. A30-A30.
189.    Lesson of the month 2: The limitations of steroid therapy in bradykinin-mediated angioedema attacks Ismail, S., et al., Clinical Medicine, 2015. 15(1): p. 101-103.
190.    Tissue factor expression on the surface of monocytes from a patient with hereditary angioedema Iwamoto, K., et al., Journal of Dermatology, 2014. 41(10): p. 929-932.
191.    Icatibant to treat an acquired angioedema crisis related to C1 inhibitor deficiency Jacob, J., et al., Emergencias, 2014. 26(4): p. 322-322.
192.    RESOLUTION OF URTICARIA AND ANGIOEDEMA ASSOCIATED WITH CARCINOID SYNDROME AFTER TRANSARTERIAL CHEMOEMBOLIZATION Jacobs, T. and A. Petrov, Annals of Allergy Asthma & Immunology, 2013. 111(5): p. A59-A59.
193.    Gastrointestinal Manifestations, D., and Management of Hereditary Angioedema Jalaj, Sujai and J.S. Scolapio, Journal of Clinical Gastroenterology, 2013. 47(10): p. 817-823.
194.    Experiences with Icatibant in Adolescent Girl with Hereditary Angioedema Jesenak, M. and P. Banovcin, Journal of Clinical Immunology, 2014. 34: p. S352-S352.
195.    Family with Hereditary Angioedema Type I Caused by Novel Mutation Jesenak, M., P. Banovcin, and T. Freiberger, Journal of Clinical Immunology, 2014. 34: p. S247-S247.
196.    A UK national audit of hereditary and acquired angioedema Jolles, S., et al., Clinical and Experimental Immunology, 2014. 175(1): p. 59-67.
197.    A novel assay to diagnose hereditary angioedema utilizing inhibition of bradykinin-forming enzymes Joseph, K., et al., Allergy, 2015. 70(1): p. 115-119.
198.    UNUSUAL CASE OF ACQUIRED ANGIOEDEMA PRESENTING INITIALLY AS HEREDITARY ANGIOEDEMA Joseph, M., Annals of Allergy Asthma & Immunology, 2014. 113(5): p. A65-A66.
199.    Angioedema in patients treated with sirolimus and ACE inhibitor post hematopoietic SCT Jung, M., et al., Bone Marrow Transplantation, 2014. 49(11): p. 1448-1449.
200.    Endothelial cell activation during edematous attacks of hereditary angioedema types I and II Kajdacsi, E., et al., Journal of Allergy and Clinical Immunology, 2014. 133(6): p. 1686-1691.
201.    Assessment of hereditary angioedema treatment risks Kalaria, S. and T. Craig, Allergy and Asthma Proceedings, 2013. 34(6): p. 519-522.
202.    Treatment of Hereditary Angioedema in the Pediatric Patient Kalaria, S. and T. Craig, Pediatric Allergy Immunology and Pulmonology, 2014. 27(4): p. 171-175.
203.    A case of recurrent angioedema in a 12-year-old girl Kalpaklioglu, A.F. and A. Baccioglu, Allergy, 2014. 69: p. 488-488.
204.    Icatibant for the treatment of hereditary angioedema Kalra, N. and T. Craig, Expert Opinion on Orphan Drugs, 2014. 2(7): p. 743-750.
205.    Treatment Of Hereditary Angioedema At The Time Of Prodromal Symptoms: International Survey Of Physicians Kalra, N. and T.J. Craig, Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB39-AB39.
206.    A novel mutation at the C1 inhibitor gene, G.W., as the cause of hereditary angioedema in a Turkish family Keskin, O., et al., Allergy, 2014. 69: p. 484-484.
207.    A MISTAKEN CASE OF ANGIOEDEMA Keswani, A. and A.T. Peters, Annals of Allergy Asthma & Immunology, 2013. 111(5): p. A68-A68.
208.    ANGIOEDEMA: AN UNCOMMON BUT POTENTIALLY LIFE-THREATENING DRUG REACTION OF APIXIBAN Khan, A., et al., Cardiology, 2014. 128: p. 502-502.
209.    Episodic angioedema with eosinophilia (Gleich syndrome) is a multilineage cell cycling disorder Khoury, P., et al., Haematologica, 2015. 100(3): p. 300-307.
210.    Angioedema deaths in the United States, -.K., Susan J., et al., Annals of Allergy Asthma & Immunology, 2014. 113(6): p. 630-634.
211.    THE DILEMMA OF HEREDITARY ANGIOEDEMA PATIENTS WITH POLYCYSTIC OVARY SYNDROME Kim, Y.M. and T.J. Craig, Annals of Allergy Asthma & Immunology, 2013. 111(5): p. A58-A58.
212.    New Perspectives in Acquired Angioedema Kivity, S., Israel Medical Association Journal, 2014. 16(5): p. 313-314.
213.    PROBABLE LABETALOL-INDUCED ANGIOEDEMA: A CASE REPORT Kobayashi, A. and S. Acquah, Journal of General Internal Medicine, 2014. 29: p. S414-S415.
214.    Severe side effects in 22 patients with hereditary angioedema using different dosage of danazol - how to switch to other treatment regimen? Kreuz, W., et al., Allergy, 2014. 69: p. 487-487.
215.    A PERPLEXING CASE OF ANGIOEDEMA Kubicz, G. and C. Mikita, Annals of Allergy Asthma & Immunology, 2013. 111(5): p. A54-A54.
216.    Assessment of home infusion program for treating nonlaryngeal hereditary angioedema attacks Kuhlen, J., et al., Annals of Allergy Asthma & Immunology, 2014. 112(5): p. 471-472.
217.    Effectiveness of omalizumab in a patient with a life-threatening episode of bronchospasm and larynx angioedema after exposure to house dust Kuprys-Lipinska, I., et al., Postepy Dermatologii I Alergologii, 2014. 31(1): p. 39-44.
218.    Acebrophylline-induced angioedema Kuriachan, S., et al., Indian Journal of Pharmacology, 2015. 47(2): p. 219-220.
219.    A patient with steroids and antihistaminic drug allergy and newly occurred chronic urticaria angioedema: What about Omalizumab? Kutlu, A., et al., Human & Experimental Toxicology, 2014. 33(8): p. 882-885.
220.    Characteristics Of Anaphylaxis and Angioedema In Pediatric Emergency Center Kwon, J.H. and H.S. Keum, Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB22-AB22.
221.    A critical appraisal of omalizumab as a therapeutic option for chronic refractory urticaria/angioedema Lang, D.M., Annals of Allergy Asthma & Immunology, 2014. 112(4): p. 276-279.
222.    Evidence-based diagnosis and treatment of chronic urticaria/angioedema Lang, D.M., Allergy and Asthma Proceedings, 2014. 35(1): p. 10-16.
223.    PROTRACTED COURSE OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR-INDUCED ANGIOEDEMA Lapinel, N.C., C. Mason, and S. Kamboj, Journal of Investigative Medicine, 2015. 63(2): p. 411-411.
224.    Angioedema of the tongue with an unfamiliar final diagnosis LaSorda, M.W. and G.V. Marcotte, Annals of Allergy Asthma & Immunology, 2015. 114(4): p. 269-272.
225.    Angioedema: Differential diagnosis Launay, D., Presse Medicale, 2015. 44(1): p. 30-36.
226.    Urticaria and Angioedema in Pregnancy and Lactation Lawlor, F., Immunology and Allergy Clinics of North America, 2014. 34(1): p. 149-+.
227.    Audit report and systematic review of orolingual angioedema in post-acute stroke thrombolysis Lekoubou, A., et al., Neurological Research, 2014. 36(7): p. 687-694.
228.    Long term follow-up of a hereditary angioedema patient treated with attenuated androgens Leru, P.M., Allergy, 2014. 69: p. 490-490.
229.    Examination of genetic variants involved in generation and biodisposition of kinins in patients with angioedema Levy, J., et al., Allergy Asthma and Clinical Immunology, 2014. 10.
230.    Ecallantide for the Acute Treatment of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Multicenter, R., Controlled Trial Lewis, Lawrence M., et al., Annals of Emergency Medicine, 2015. 65(2): p. 204-213.
231.    COMPARISON OF CHROMOGENIC AND ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TESTING METHODS OF FUNCTIONAL C1 ESTERASE INHIBITOR (C1 INH) IN DIAGNOSING HEREDITARY ANGIOEDEMA (HAE) Li, H., et al., Annals of Allergy Asthma & Immunology, 2013. 111(5): p. A16-A17.
232.    EFFICACY AND SAFETY OF RECOMBINANT HUMAN C1 ESTERASE INHIBITOR FOR ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA: AN OPEN-LABEL STUDY Li, H., et al., Annals of Allergy Asthma & Immunology, 2013. 111(5): p. A92-A93.
233.    EFFICACY OF RECOMBINANT HUMAN C1 INHIBITOR FOR THE TREATMENT OF HEREDITARY ANGIOEDEMA PATIENTS WITH SEVERE ATTACKS Li, H., et al., Annals of Allergy Asthma & Immunology, 2014. 113(5): p. A5-A5.
234.    Sustained Response Following Acute Treatment Of Hereditary Angioedema Attacks With Recombinant Human C1 Esterase Inhibitor Li, H.H., et al., Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB37-AB37.
235.    ANGIOEDEMA AND LOW C1 ESTERASE INHIBITOR FUNCTION DURING PREGNANCY Lin, E., et al., Internal Medicine Journal, 2014. 44: p. 31-32.
236.    PROTRACTED ANGIOEDEMA IN A 9-YEAR-OLD GIRL: PROPOFOL AND FOOD ALLERGY Lin, S.K. and T.B. Fausnight, Annals of Allergy Asthma & Immunology, 2014. 113(5): p. A58-A58.
237.    Orolingual angioedema after alteplase therapy of acute ischaemic stroke: incidence and risk of prior angiotensin-converting enzyme inhibitor use Lin, S.Y., et al., European Journal of Neurology, 2014. 21(10): p. 1285-1291.
238.    Risk Factors Associated With Severe and Recurrent Angioedema: An Epidemic Linked to ACE-Inhibitors Loftus, P.A., et al., Laryngoscope, 2014. 124(11): p. 2502-2507.
239.    Angioedema and severe abdominal distention: a case report Loloci, G., et al., Allergy, 2014. 69: p. 320-320.
240.    Melkersson-Rosenthal syndrome misdiagnosed as refractory angioedema: a case report Loloci, G., et al., Allergy, 2014. 69: p. 319-319.
241.    The Icatibant Outcome Survey: treatment of laryngeal hereditary angioedema attacks Longhurst, H., et al., Allergy, 2014. 69: p. 53-54.
242.    Real-world outcomes in hereditary angioedema: first experience from the icatibant outcome survey in the United Kingdom Longhurst, H., et al., Clinical and Experimental Allergy, 2015. 45(2): p. 499-499.
243.    The Icatibant Outcome Survey: Characteristics Of Patients With Hereditary Angioedema Requiring Reinjection Longhurst, H., et al., Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB34-AB34.
244.    Expression of the SERPING1 gene is not regulated by promoter hypermethylation in peripheral blood mononuclear cells from patients with hereditary angioedema due to C1-inhibitor deficiency Lopez-Lera, A., et al., Orphanet Journal of Rare Diseases, 2014. 9.
245.    Most Hereditary Angioedema (HAE) Attacks Resolved After One Icatibant Injection: Analysis Of FAST-3 Open-Label Extension Study Lumry, W.R., et al., Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB35-AB35.
246.    Health-related quality of life (HRQoL) in patients with hereditary angioedema (HAE) receiving nanofiltered C1 inhibitor (C1 INH-nf) for prophylaxis: results of a randomised, p.-c., et al., Allergy, 2014. 69: p. 491-491.
247.    Quality of life in patients with hereditary angioedema receiving therapy for routine prevention of attacks Lumry, W.R., et al., Allergy and Asthma Proceedings, 2014. 35(5): p. 371-376.
248.    Future Therapy for Pediatric Hereditary Angioedema MacGinnitie, A.J., Pediatric Allergy Immunology and Pulmonology, 2014. 27(4): p. 177-180.
249.    Pediatric hereditary angioedema MacGinnitie, A.J., Pediatric Allergy and Immunology, 2014. 25(5): p. 420-427.
250.    Professional Administration Costs In The US For On-Demand Therapy Of Hereditary Angioedema Machnig, T. and A. Zbrozek, Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB38-AB38.
251.    Presence of C1-Inhibitor Polymers in a Subset of Patients Suffering from Hereditary Angioedema Madsen, D.E., et al., Plos One, 2014. 9(11).
252.    A Case of Nonepisodic Angioedema With Eosinophilia Associated With Livedo Reticularis and Erythema Before Onset of Edema of the Legs Maejima, H. and K. Katsuoka, Cutis, 2014. 93(1): p. 33-37.
253.    Drug safety in Aboriginal Australians: three cases of angiotensin-converting enzyme inhibitor angioedema Mahajan, H., et al., Internal Medicine Journal, 2015. 45(2): p. 231-233.
254.    Hereditary angioedema. Treatment of acute attacks in Argentina Malbran, A., et al., Medicina-Buenos Aires, 2014. 74(3): p. 198-200.
255.    Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial Malbran, A., et al., Clinical and Experimental Immunology, 2014. 177(2): p. 544-553.
256.    Use of recombinant Cl inhibitor in patients with resistant or frequent attacks of hereditary or acquired angioedema Manson, A.L., et al., European Journal of Dermatology, 2014. 24(1): p. 28-34.
257.    Time necessary to perform serum C4 and C1-INH quantitative determinations by nephelometry in patients with angioedema without urticaria Mariana, V. and P. Florin-Dan, Clinical Biochemistry, 2014. 47(9): p. 776-776.
258.    Hereditary angioedema with normal C1INH without FXII mutations: description of a family Marques, L., et al., Allergy, 2014. 69: p. 490-491.
259.    Revising the nosology of bradykinin-mediated angioedema Martin, L., H. Humeau, and M.E. Sarre, Annales De Dermatologie Et De Venereologie, 2015. 142(3): p. 159-161.
260.    Delayed diagnosis of hereditary angioedema: a case report of 39 years of misdiagnosis and inadequate treatment Martinez-Saguer, I., K. Andritschke, and W. Kreuz, Allergy, 2014. 69: p. 488-488.
261.    Pharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study Martinez-Saguer, I., et al., Transfusion, 2014. 54(6): p. 1552-1561.
262.    SUCCESSFUL SWITCH FROM LONG-TERM PROPHYLAXIS WITH DANAZOL TO ACUTE TREATMENT WITH C1 ESTERASE INHIBITOR CONCENTRATE (BERINERT) IN A PATIENT WITH HEREDITARY ANGIOEDEMA Martinez-Saguer, I. and W. Kreuz, Annals of Allergy Asthma & Immunology, 2014. 113(5): p. A101-A102.
263.    Occurrence of ecchymotic angioedema-like cutaneous lesions as a possible side effect of fingolimod Masera, S., et al., Multiple Sclerosis Journal, 2014. 20(12): p. 1666-1667.
264.    Argentine Guidelines for Urticaria and Angioedema Maspero, J., et al., Medicina-Buenos Aires, 2014. 74: p. 1-53.
265.    Treatment of hereditary angioedema with icatibant: Efficacy in clinical trials versus effectiveness in the real-world setting Maurer, M., et al., Allergy and Asthma Proceedings, 2014. 35(5): p. 377-381.
266.    Angioedema secondary to angiotensin converting enzyme inhibitors is not due to C1 esterase inhibitor deficiency McLean-Tooke, A., Pediatric Radiology, 2014. 44(7): p. 897-898.
267.    Angioedema by cocaine: an unusual complication Mezquida Arno, J., T. Escolar Martinez-Berganza, and M.d.C. Lahoza Perez, Emergencias, 2014. 26(6): p. 496-496.
268.    Epidemiological and clinical profile of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers-induced angioedema at the emergency department Micozzi, S., et al., Allergy, 2014. 69: p. 555-556.
269.    Hereditary Angioedema: Severity, C.F.a.M.B.S.F.-U.M.S.S., Fernanda Gontijo, et al., Journal of Clinical Immunology, 2014. 34(3): p. 365-365.
270.    Effectiveness of Long-Term Use of Danazol in Hereditary Angioedema: 10 Years of Follow-Up at The Hospital Das Clinicas-UFMG Minafra Silveira Santos, F.G., et al., Journal of Clinical Immunology, 2014. 34(3): p. 381-381.
271.    A Case Series Of Seven Pediatric Patients Successfully Treated With Ecallantide and Icatibant For Hereditary Angioedema Minto, H. and K.M. Maples, Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB33-AB33.
272.    Rifampin induced angioedema: a rare but serious side effect Mirsaeidi, M. and D. Schraufnagel, Brazilian Journal of Infectious Diseases, 2014. 18(1): p. 102-103.
273.    Evaluation Of DX-88 (Ecallantide) For Treatment Of Angiotensin Enzyme Inhibitor Induced Angioedema In The Emergency Department Moellman, J., et al., Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB38-AB38.
274.    A Consensus Parameter for the Evaluation and Management of Angioedema in the Emergency DepartmentUn Parametro de Consenso para la Evaluacion y Tratamiento del Angioedema en el Servicio de Urgencias Moellman, J., et al., Academic Emergency Medicine, 2014. 21(4): p. 469-484.
275.    Ultrasound assessment of acute abdominal pain in hereditary angioedema Montoro, S., et al., Anales De Pediatria, 2014. 81(1): p. 58-59.
276.    Structural and Molecular Changes Caused By Mutations Thr328Lys and Thr328Arg In FXII Associated With Hereditary Angioedema With Normal C1 Inhibitor Moreno, A.S., et al., Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB39-AB39.
277.    Angioedema in bradykinin: the efficient treatments exist, i.w.b.n.t.b.a.t.h.i.q.M., F., et al., Annales Francaises D Anesthesie Et De Reanimation, 2014. 33: p. A346-A347.
278.    Screening of underlying causes in acute urticaria and/or angioedema Muresan, A.M., L.G. Popa, and C. Giurcaneanu, Allergy, 2014. 69: p. 318-318.
279.    Angiotensin Receptor Blocker-Induced Visceral Angioedema Muthukrishnan, T.P., et al., Journal of Investigational Allergology and Clinical Immunology, 2015. 25(1): p. 63-64.
280.    Ecallantide In Treatment Of Type III Hereditary Angioedema Nanda, A. and A.N. Wasan, Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB38-AB38.
281.    A cross-sectional questionnaire assessing patient and physician use of short-term prophylaxis for hereditary angioedema Nanda, M.K., et al., Annals of Allergy Asthma & Immunology, 2014. 113(2): p. 198-203.
282.    Quantifying the burden of disease and perceived health state in patients with hereditary angioedema in Sweden (vol 35, p., 2014) Nordenfelt, Patrik, Allergy and Asthma Proceedings, 2014. 35(3): p. 259-259.
283.    Quantifying the burden of disease and perceived health state in patients with hereditary angioedema in Sweden Nordenfelt, P., et al., Allergy and Asthma Proceedings, 2014. 35(2): p. 185-190.
284.    Clinical and Laboratory Characteristics That Differentiate Hereditary Angioedema in 72 Patients with Angioedema Ohsawa, I., et al., Allergology International, 2014. 63(4): p. 595-602.
285.    GLOBAL AVAILABILITY OF HEREDITARY ANGIOEDEMA DRUGS Onyango, N., K. Karikari, and T. Craig, Annals of Allergy Asthma & Immunology, 2014. 113(5): p. A107-A107.
286.    Management of risk medical and surgical procedures in patients with bradykinin mediated angioedema Palao-Ocharan, P., et al., Allergy, 2014. 69: p. 485-485.
287.    A Case of Persistent Angioedema Panasoff, J.H., Journal of Investigational Allergology and Clinical Immunology, 2014. 24(2): p. 142-142.
288.    Presence of unilateral angioedema predicts aetiology and clinical phenotypes, a.i.a.w.m.b.B.P., A. P., et al., Clinical and Experimental Allergy, 2015. 45(2): p. 500-501.
289.    A Case of Eosinophilic Gastroenteritis Initially Misdiagnosed as Idiopathic Intestinal Angioedema Patel, V., K. Karia, and D. Wan, American Journal of Gastroenterology, 2014. 109: p. S326-S326.
290.    Long-term Prophylaxis With C1-Inhibitor Concentrate in Patients With Hereditary Angioedema Pedrosa, M., et al., Journal of Investigational Allergology and Clinical Immunology, 2014. 24(4): p. 271-273.
291.    Management of angioedema without urticaria in the emergency department Pedrosa, M., et al., Annals of Medicine, 2014. 46(8): p. 607-618.
292.    Early Presentation of clinical hereditary angioedema (HAE) symptoms in a neonate Pham, H., S. Santucci, and W.H. Yang, Allergy, 2014. 69: p. 484-485.
293.    Variability in mast cell activation genes SYK, L., PLCG1, PLA2G4A and TNFRS11A in patients with NSAID-induced urticaria and/or angioedema (NIUA) Plaza-Seron, M. D. C., et al., Allergy, 2014. 69: p. 376-377.
294.    Hereditary angioedema biological diagnosis Ponard, D., Presse Medicale, 2015. 44(1): p. 57-64.
295.    Autoimmune urticaria and angioedema masquerading as aniseed allergy Popescu, F.D. and M. Vieru, Allergy, 2014. 69: p. 462-462.
296.    BSACI guideline for the management of chronic urticaria and angioedema Powell, R.J., et al., Clinical and Experimental Allergy, 2015. 45(3): p. 547-565.
297.    IHAE-Qol: Specific Health-Related Quality Of Life (HRQoL) Questionnaire In Hereditary Angioedema Due To C1 Inhibitor Deficiency (HAE-C1INH) Prior, N., et al., Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB33-AB33.
298.    Hereditary Angioedema in Greece: The First Results of the Greek Hereditary Angioedema Registry Psarros, F., et al., International Archives of Allergy and Immunology, 2014. 164(4): p. 326-332.
299.    A Rare Case of Intramuscular Diclofenac Induced Angioedema and Lacrimation Raikar, S., et al., Indian Journal of Pharmacology, 2013. 45: p. S58-S58.
300.    ESTIMATING THE RISK OF ANGIOEDEMA ASSOCIATED WITH USE OF DIPEPTIDYL-PEPTIDASE INHIBITORS Ramachandran, S., Value in Health, 2014. 17(3): p. A103-A103.
301.    AN UNUSUAL CASE OF RECURRENT ABDOMINAL PAIN SIMULATING ANGIOEDEMA Rampur, L., A. Rubinstein, and Z. Ren, Annals of Allergy Asthma & Immunology, 2014. 113(5): p. A76-A76.
302.    Angiotensin-converting Enzyme Inhibitor-induced Angioedema - A Dangerous New Epidemic Rasmussen, E.R., K. Mey, and A. Bygum, Acta Dermato-Venereologica, 2014. 94(3): p. 260-264.
303.    A case report looking at ACE inhibitors as the cause of angioedema during dental treatment Raval, P., British Dental Journal, 2014. 216(2).
304.    Paediatric hereditary angioedema: a survey of UK service provision and patient experience Read, N., et al., Clinical and Experimental Immunology, 2014. 178(3): p. 483-488.
305.    WAS TRAUMA THE CAUSE? A CASE OF HEREDITARY ANGIOEDEMA Reddy, M.B., Annals of Allergy Asthma & Immunology, 2014. 113(5): p. A79-A79.
306.    TREATMENT WITH RECOMBINANT HUMAN C1 INHIBITOR SHORTENS DURATION OF HEREDITARY ANGIOEDEMA ATTACK SYMPTOMS Riedl, M., et al., Annals of Allergy Asthma & Immunology, 2014. 113(5): p. A106-A106.
307.    Creating a Comprehensive Treatment Plan for Hereditary Angioedema Riedl, M.A., Immunology and Allergy Clinics of North America, 2013. 33(4): p. 471-+.
308.    The therapeutic landscape for hereditary angioedema: more change on the horizon? Riedl, M.A., Annals of Allergy Asthma & Immunology, 2014. 113(4): p. 337-338.
309.    Critical appraisal of androgen use in hereditary angioedema: a systematic review Riedl, M.A., Annals of Allergy Asthma & Immunology, 2015. 114(4): p. 281-+.
310.    Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, r., placebo-controlled trial Riedl, Marc A., et al., Annals of Allergy Asthma & Immunology, 2014. 112(2): p. 163-+.
311.    Current Medical Management Of Hereditary Angioedema (HAE): Follow-Up To a Large Survey Of US Physicians Riedl, M.A., R.G. Gower, and A. Banerji, Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB31-AB31.
312.    Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema Riedl, M.A., et al., American Journal of Rhinology & Allergy, 2013. 27(6): p. 517-521.
313.    Treatment With Off-Label Omalizumab In Chronic Idiopathic Histaminergic Urticaria - Angioedema Resistant To Conventional Treatment Rijo, Y.V., et al., Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB118-AB118.
314.    A CASE OF IRBESARTAN-INDUCED ANGIOEDEMA WITH SEVERE LARYNGEAL EDEMA Rishi, R., S. Ringwala, and S. Fatteh, Annals of Allergy Asthma & Immunology, 2014. 113(5): p. A53-A53.
315.    Hereditary angioedema involving the duodenum. An unusual cause of upper abdominal pain Robert, B., Presse Medicale, 2015. 44(3): p. 370-371.
316.    Rapid Iron Desensitization After Generalized Urticaria and Facial Angioedema Rodriguez-Jimenez, B., et al., Journal of Investigational Allergology and Clinical Immunology, 2014. 24(1): p. 69-71.
317.    DELAYED DIAGNOSIS OF ERYTHROPOIETIC PROTOPORPHYRIA: A 36 YEAR OLD HISPANIC FEMALE WITH SUN-INDUCED ANGIOEDEMA Rodriguez-Roa, M. and S. Nazario, Annals of Allergy Asthma & Immunology, 2014. 113(5): p. A118-A118.
318.    Coexistence of Angioedema Alone with Impaired Glucose Tolerance Rogala, B., et al., International Archives of Allergy and Immunology, 2014. 165(4): p. 265-269.
319.    Pasteurised nanofiltered C1-inhibitor concentrate (pnf C1-INH, B.f.p.o.a.i.h.a.H.r.f.a.o.r.R., M., et al., Allergy, 2014. 69: p. 489-489.
320.    Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency Rubinstein, E., et al., Bmc Gastroenterology, 2014. 14.
321.    Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE) Sabharwal, G. and T. Craig, Expert Review of Clinical Immunology, 2015. 11(3): p. 319-327.
322.    Self-Administration Of a Novel Subcutaneous Bradykinin B2 Receptor Antagonist, I.F.R., As An Effective Treatment Option In Patients With Hereditary Angioedema (HAE) Santucci, Stephanie, et al., Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB31-AB31.
323.    Perioperative Management of Tooth Extractions for a Patient With Hereditary Angioedema Sanuki, T., et al., Journal of Oral and Maxillofacial Surgery, 2014. 72(12).
324.    An allergic transfusion reaction with angioedema Savage, W.J. and R.M. Kaufman, Transfusion, 2014. 54(8): p. 1916-1916.
325.    A pilot study on the role of stress and emotional processes in the variability of hereditary angioedema (HAE) in childhood and adolescence Savarese, L., et al., Allergy, 2014. 69: p. 483-483.
326.    Findings of a clinical response survey in physicians caring for patients with hereditary angioedema Schranz, J. and D. Fitts, Allergy, 2014. 69: p. 486-486.
327.    Findings of a clinical response survey in patients with hereditary angioedema Schranz, J., D. Fitts, and P. King, Allergy, 2014. 69: p. 486-486.
328.    Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema less than 12 years of age Schranz, J., et al., Allergy, 2014. 69: p. 491-491.
329.    Development of C1-inhibitor antibodies in a patient with hereditary angioedema Seneviratne, S., et al., Clinical and Experimental Immunology, 2013. 174: p. 28-28.
330.    C1-esterase inhibitor antibodies in a patient with type 1 hereditary angioedema Seneviratne, S., et al., Allergy, 2014. 69: p. 487-487.
331.    Incidence and Treatment Of Angioedema In a Third Level Spanish Hospital Seoane, M., et al., Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB40-AB40.
332.    Q: Can an ARB be given to patients who have had angioedema on an ACE inhibitor? Sharma, P. and V. Nagarajan, Cleveland Clinic Journal of Medicine, 2013. 80(12).
333.    Hereditary Angioedema as the Cause of Death from Asphyxia: Postmortem Computed Tomography Study Shibuya, M., et al., Allergology International, 2014. 63(3): p. 493-494.
334.    Caesarean delivery in a parturient with type III hereditary angioedema Soltanifar, D., et al., International Journal of Obstetric Anesthesia, 2014. 23(4): p. 398-399.
335.    Angioedema in the neurointerventional suite Sonny, A., et al., Journal of Clinical Anesthesia, 2015. 27(2): p. 170-174.
336.    A 31-year-old pregnant woman with angioedema Speck, A.L., P.D. Killen, and M.J. Greenhawt, Allergy and Asthma Proceedings, 2015. 36(2): p. 160-165.
337.    Hereditary angioedema: Molecular and clinical differences among European populations Speletas, M., et al., Journal of Allergy and Clinical Immunology, 2015. 135(2): p. 570-+.
338.    Cost-minimization of innovative C1-inhibitor self-administration strategies in Hereditary Angioedema Squeglia, V., et al., Allergy, 2014. 69: p. 493-493.
339.    Life-threatening angioedema induced by angiotensin-converting enzyme inhibitors: Characteristics and risk factors Stauber, T., R. Confino-Cohen, and A. Goldberg, American Journal of Rhinology & Allergy, 2014. 28(1): p. 54-58.
340.    Hereditary Angioedema Without C1 Inhibitor Deficiency: Observation Of Patients Homozygous For FXII GENE Mutation Stieber, C., et al., Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB31-AB31.
341.    High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency Suffritti, C., et al., Clinical and Experimental Allergy, 2014. 44(12): p. 1503-1514.
342.    Introducing the International Hereditary Angioedema Nurses Organisation (IHNO) Symons, C., et al., Journal of Clinical Immunology, 2014. 34: p. S511-S511.
343.    Current characteristics associated with hereditary angioedema attacks and treatment: The home infusion based patient experience Tachdjian, R., et al., Allergy and Asthma Proceedings, 2015. 36(2): p. 151-159.
344.    A CASE OF LATE-ONSET ANGIOEDEMA DUE TO CLOZAPINE AND REDEVELOPMENT OF ANGIOEDEMA WITH OLANZAPINE Tatar, Z.B. and S. Oflaz, European Psychiatry, 2014. 29.
345.    A Case of Late-Onset Angioedema Associated With Clozapine and Redevelopment of Angioedema With Olanzapine Tatar, Z.B., S. Oflaz, and B. Baran, Journal of Clinical Psychopharmacology, 2014. 34(4): p. 523-525.
346.    Sonographic Appearance of Angioedema in Local Allergic Reactions to Insect Bites and Stings Tay, E.T. and J.W. Tsun, Journal of Ultrasound in Medicine, 2014. 33(9): p. 1705-1710.
347.    Serum TARC levels correlate with disease activity in patients with non-episodic angioedema with eosinophilia Teraki, Y. and R. Taguchi, Journal of Dermatology, 2014. 41(9): p. 858-860.
348.    Alteplase (tPA) Induced Angioedema in a Patient with a History of ACE-Inhibitor Use Ternas, T., D. Garcia, and N. Zerilli, Critical Care Medicine, 2013. 41(12).
349.    Urticaria y angioedema: una visión general Tincopa-Wong, Ó.W., Acta Médica Peruana, 2014. 31(2): p. 111-124.
350.    Another case of the rare complications of chronic lymphocytic leukemia: angioedema Tlamcani, I., et al., Annales De Biologie Clinique, 2014. 72(4): p. 479-481.
351.    SELECTIVE IMMUNOGLOBULINE M DEFICIENCY ASSOCIATED WITH ANGIOEDEMA Topcu, Z.I.K., M.H. Abul, and F. Orhan, Journal of Clinical Immunology, 2014. 34(6): p. 723-723.
352.    Hereditary Angioedema and Autoimmunity Triggianese, P., et al., Israel Medical Association Journal, 2014. 16(10): p. 622-624.
353.    Angioedema Probably Related to Fluoxetine in a Preadolescent Being Followed Up for Major Depressive Disorder Tuman, T.C., et al., Journal of Child and Adolescent Psychopharmacology, 2013. 23(10): p. 697-698.
354.    Barriers to self-administered therapy for hereditary angioedema Tuong, L.-A.C., K. Olivieri, and T.J. Craig, Allergy and Asthma Proceedings, 2014. 35(3): p. 250-254.
355.    Spectrum and Management of Complement Immunodeficiencies (Excluding Hereditary Angioedema) Across Europe Turley, A.J., et al., Journal of Clinical Immunology, 2015. 35(2): p. 199-205.
356.    Case of angioedema and urticaria induced by lenalidomide Uchiyama, A., et al., Journal of Dermatology, 2014. 41(2): p. 179-181.
357.    Hereditary angioedema (HAE) profile of patients followed up in a reference center in Rio de Janeiro - Brazil Valle, S.O.R., et al., Allergy, 2014. 69: p. 583-584.
358.    Seeming Tongue Swelling Responding To Nebulized Ipratropium In An Individual With A Diagnosis Of Type III HAE (Hereditary Angioedema) Vegh, J., A.B. Vegh, and N. Butler, Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB41-AB41.
359.    Bradykinin-Mediated Hereditary Angioedema (Non-Estrogen-Dependent) Without C1 Inhibitor Deficiency Vela Vizcaino, C., et al., Journal of Investigational Allergology and Clinical Immunology, 2014. 24(4): p. 280-281.
360.    SICK TO YOUR STOMACH: IATROGENIC BOWEL ANGIOEDEMA Velez, C., E. Stevens, and R.L. Goodman, Journal of General Internal Medicine, 2014. 29: p. S434-S434.
361.    Recurrent angioedema after naproxen use in a patient stabilized with losartan Venci, J.V. and J.A. Shamaskin, Annals of Allergy Asthma & Immunology, 2014. 113(6): p. 666-667.
362.    Disease severity in hereditary angioedema due to C1-inhibitor deficiency Veszeli, N., et al., Allergy, 2014. 69: p. 485-485.
363.    Anaphylaxis/angioedema caused by honey ingestion Vezir, E., et al., Allergy and Asthma Proceedings, 2014. 35(1): p. 71-74.
364.    Isolated Uvular Angioedema Viana-Tejedor, A. and I. Javier Nunez-Gil, New England Journal of Medicine, 2014. 370(15).
365.    Recurrent angioedema in a 40-year-old woman - a case report Vieira, M., et al., Allergy, 2014. 69: p. 320-320.
366.    Hereditary angioedema - from genotype to phenotype Vieira, M., et al., Allergy, 2014. 69: p. 483-483.
367.    Odontological Treatment in Patients with Hereditary Angioedema Vilarim, R.C.B., et al., Journal of Clinical Immunology, 2014. 34: p. S220-S220.
368.    Benefits of hydroxychloroquine in the treatment of a patient with angioedema due to acquired C1 inhibitor deficiency Vincent, D., et al., Annals of Allergy Asthma & Immunology, 2015. 114(1): p. 68-+.
369.    Phenotype Standardization of Angioedema in the Head and Neck Region Caused by Agents Acting on the Angiotensin System Wadelius, M., et al., Clinical Pharmacology & Therapeutics, 2014. 96(4): p. 477-481.
370.    Current update on cellular and molecular mechanisms of hereditary angioedema Walford, H.H. and B.L. Zuraw, Annals of Allergy Asthma & Immunology, 2014. 112(5): p. 413-418.
371.    Orolingual angioedema associated with olmesartan use after recombinant tissue plasminogen activator treatment of acute stroke Wang, S., et al., Annals of Allergy Asthma & Immunology, 2014. 112(2): p. 177-178.
372.    Quality of life in patients with urticaria and angioedema: Assessing burden of disease Weldon, D., Allergy and Asthma Proceedings, 2014. 35(1): p. 4-9.
373.    Facial Angioedema and Stroke Werner, R., M. Keller, and J.C. Woehrle, Cerebrovascular Diseases, 2014. 38(2): p. 101-106.
374.    Pulmonary embolism complicating high dose tranexamic acid therapy for idiopathic angioedema Whelan, B. and H.S. Jenkins, Clinical and Experimental Allergy, 2013. 43(12): p. 1446-1446.
375.    Ludwig's Angina Masquerading As Angioedema Wiens, L.A., Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB40-AB40.
376.    Evaluating for seasonal variation in angiotensin-converting enzyme inhibitor-and angiotensin receptor blocker-induced angioedema Wilson, M., et al., Annals of Allergy Asthma & Immunology, 2014. 112(2): p. 178-179.
377.    Characteristics of Renin Angiotensin System Blockers-induced Angioedema in Thailand Win, T.S.Z., et al., International Journal of Clinical Pharmacy, 2013. 35(6): p. 1292-1292.
378.    Tranexamic acid as maintenance treatment for non-histaminergic angioedema: analysis of efficacy and safety in 37 patients Wintenberger, C., et al., Clinical and Experimental Immunology, 2014. 178(1): p. 112-117.
379.    Management of Hereditary Angioedema in Childhood Wu, E.Y. and M.M. Frank, Pediatric Allergy Immunology and Pulmonology, 2014. 27(4): p. 165-169.
380.    Asymmetric oro-facial angioedema following alteplase for acute ischaemic stroke Wu, T.Y., et al., Journal of Clinical Neuroscience, 2014. 21(11): p. 2004-2006.
381.    Upper airway edema in 43 patients with hereditary angioedema Xu, Y.-Y., et al., Annals of Allergy Asthma & Immunology, 2014. 112(6): p. 539-U157.
382.    Successful treatment of angiotensin- converting enzyme inhibitor angioedema with fresh frozen plasma Yates, C., et al., Clinical Toxicology, 2014. 52(4): p. 407-408.
383.    Progesterone Skin Test in Severe Attacks of Angioedema during Menstrual Cycle Yerebasmaz, N., et al., Iranian Journal of Allergy Asthma and Immunology, 2014. 13(5): p. 375-377.
384.    OMALIZUMAB MAY PREVENT PERFUME TRIGGERED LARYNGEAL ANGIOEDEMA Young, R.M. and P. Ciminera, Annals of Allergy Asthma & Immunology, 2014. 113(5): p. A59-A59.
385.    Subcutaneous Immunoglobulins in Prevention of Hereditary Angioedema Attacks Zachova, R., et al., Journal of Clinical Immunology, 2014. 34: p. S311-S311.
386.    A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy Zanichelli, A., et al., Allergy, 2014. 69: p. 52-52.
387.    A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy Zanichelli, A., et al., Orphanet Journal of Rare Diseases, 2015. 10.
388.    Development of a Shared Clinical Pathway for Taking Charge of Patients with Hereditary and Acquired C1 Estherase Inhibitor Deficiency Angioedema Zanierato, G., et al., Journal of Clinical Immunology, 2014. 34: p. S503-S504.
389.    Symptomatic, A.a.A.M.F.A.I.a.A.I.P.I.S.T.E.T.E.a.S.O.O.I.P.W.C.I.S.U.W.R., et al., Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB117-AB117.
390.    Hereditary angioedema-induced acute pancreatitis: a case report Zeyrek, D., A. Cakmak, and S. Geter, Allergy, 2014. 69: p. 487-488.
391.    Seasonal Increase In Angioedema In An Inner City Hospital Center Zhou, H., A. Mathew, and R. Joks, Journal of Allergy and Clinical Immunology, 2014. 133(2): p. AB40-AB40.
392.    The influence of trigger factors on hereditary angioedema due to C1-inhibitor deficiency Zotter, Z., et al., Orphanet Journal of Rare Diseases, 2014. 9.
393.    Glucocorticoid polymorphism in patients with hereditary angioedema due to C1-INH deficiency Zotter, Z., et al., Allergy, 2014. 69: p. 484-484.
394.    Frequency of the virilising effects of attenuated androgens reported by women with hereditary angioedema Zotter, Z., et al., Orphanet Journal of Rare Diseases, 2014. 9.
395.    LONG-TERM PROPHYLACTIC TREATMENT OF HEREDITARY ANGIOEDEMA: FINDINGS FROM AN INTERNATIONAL HEREDITARY ANGIOEDEMA EXPERT SURVEY Zuraw, B., et al., Annals of Allergy Asthma & Immunology, 2014. 113(5): p. A88-A89.
396.    Dose-ranging trial of a volume-reduced, s.f.o.a.C.-I.c.C.f.t.p.o.a.a.o.h.a.Z., B., et al., Allergy, 2014. 69: p. 52-52.
397.    Rare Disease Partnership The Role of the US HAEA in Angioedema Care Zuraw, B.L. and S.C. Christiansen, Immunology and Allergy Clinics of North America, 2013. 33(4): p. 545-+.
398.    Delayed onset urticaria and angioedema caused by components of itraconazole solution 김수영, et al., Allergy Asthma & Respiratory Diseases, 2014. 2(2): p. 138-141.